LIVIVO - Search results -

Search results

Result 1 - 10 of total 21

Search options

Article: A case report of prolonged COVID-19-positive RT-PCR for five months.

Siami, Zeinab / Jamalimoghadamsiahkali, Saeidreza / Khavandegar, Armin

2022 Volume 10, Issue 7, Page(s) e6113

Abstract: The COVID-19 gold standard assessment tool remained the RT-PCR of upper respiratory tract specimen extracted by the nasopharyngeal swab. A positive result would decrease through a three-week course and eventually be undetectable. The maximum duration of ... ...

Abstract	The COVID-19 gold standard assessment tool remained the RT-PCR of upper respiratory tract specimen extracted by the nasopharyngeal swab. A positive result would decrease through a three-week course and eventually be undetectable. The maximum duration of viral shedding is 83 days. Besides, COVID-19 RT-PCR remained positive for 74 days in a patient suffering from lymphoma. In this study, we have presented a 56-year-old male patient, a known case of lymphoma since 2015, who experienced many episodes of chemotherapy with a five-month positive RT-PCR COVID-19 laboratory test and finally was intubated and then died of opportunistic pulmonary infections. COVID-19 patients with concurrent lymphoma failed to remove the virus thoroughly, despite providing appropriate treatment regimens.
Language	English
Publishing date	2022-07-25
Publishing country	England
Document type	Case Reports
ZDB-ID	2740234-4
ISSN	2050-0904
ISSN	2050-0904
DOI	10.1002/ccr3.6113
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Preparation, characterization and in vitro evaluation of insulin-PHBV nanoparticles / alginate hydrogel composite system for prolonged delivery of insulin.

Bayrami, Samane / Chamani, Mehdi / JamaliMoghadamSiahkali, SaeidReza / SeyedAlinaghi, SeyedAhmad / Shirmard, Leila Rezaie / Bayrami, Sepide / Javar, Hamid Akbari / Ghahremani, Mohammad Hossein / Amini, Mohsen / Tehrani, Morteza Rafiee / Shahsavari, Shadab / Dorkoosh, Farid Abedin

Journal of pharmaceutical sciences

2024

Abstract: Purpose: In the present study, biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles (NPs) containing insulin were loaded in sodium alginate/jeffamine (ALG/jeff) hydrogel for prolonged delivery of insulin. The main aim of this ...

Abstract	Purpose: In the present study, biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles (NPs) containing insulin were loaded in sodium alginate/jeffamine (ALG/jeff) hydrogel for prolonged delivery of insulin. The main aim of this work was to fabricate an efficient insulin delivery system to improve patient adherence by decreasing the repetition of injections. Methods: Swelling and morphological properties and crosslinking efficiency of ALG/jeff hydrogel were assessed. The composite hydrogel was prepared by adding PHBV NPs to ALG/jeff hydrogel concurrently with crosslinking process. The morphology and loading capacity of composite hydrogel were analyzed. Results: Circular dichroism measurement demonstrated that insulin remains stable following fabrication process. The release profile exhibited 54.6% insulin release from composite hydrogel within 31 days with minor initial burst release equated to nanoparticles and hydrogels. MTT cell viability analysis was performed by applying L-929 cell line and no cytotoxic effect was observed. Conclusions: Favorable results clearly introduced fabricated composite hydrogel as an excellent candidate for drug delivery systems and also paves the route for prolonged delivery systems of other proteins.
Language	English
Publishing date	2024-03-18
Publishing country	United States
Document type	Journal Article
ZDB-ID	3151-3
ISSN	1520-6017 ; 0022-3549
ISSN (online)	1520-6017
ISSN	0022-3549
DOI	10.1016/j.xphs.2024.03.010
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uf I Zs.50: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Acupuncture or cupping plus standard care versus standard care in moderate to severe COVID-19 patients: An assessor-blinded, randomized, controlled trial.

Alipour, Reihane / Jamalimoghadamsiahkali, Saeidreza / Karimi, Mehrdad / Asadi, Asma / Ghaem, Haleh / Adel-Mehraban, Mohammad Sadegh / Kazemi, Amir Hooman

Integrative medicine research

2022 Volume 11, Issue 4, Page(s) 100898

Abstract: Background: Non-pharmacological strategies that have been proposed by complementary medical systems, can be effective in management of COVID-19.: Methods: This study was designed as a three-arm, assessor-blinded, randomized controlled trial. A total ... ...

Abstract	Background: Non-pharmacological strategies that have been proposed by complementary medical systems, can be effective in management of COVID-19. Methods: This study was designed as a three-arm, assessor-blinded, randomized controlled trial. A total of 139 hospitalized COVID-19 patients were randomly assigned into three groups: (1) acupuncture (ACUG), (2) cupping (CUPG), and (3) control (CTRG). All participants received conventional treatment. The primary study endpoint included changes in respiratory signs including oxygen saturation (SpO Results: Forty-two patients in ACUG, 44 patients in CUPG, and 42 patients in CTRG completed the trial. After 3 days, SpO Conclusion: Cupping and acupuncture are promising safe and effective therapies in management of COVID-19. Trial registration: This study was registered at Iranian Registry of Clinical Trials: IRCT20201127049504N1 (https://en.irct.ir/trial/52621).
Language	English
Publishing date	2022-10-29
Publishing country	Netherlands
Document type	Journal Article
ZDB-ID	2696588-4
ISSN	2213-4220
ISSN	2213-4220
DOI	10.1016/j.imr.2022.100898
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Acupuncture or cupping plus standard care versus standard care in moderate to severe COVID-19 patients

Reihane Alipour / Saeidreza Jamalimoghadamsiahkali / Mehrdad Karimi / Asma Asadi / Haleh Ghaem / Mohammad Sadegh Adel-Mehraban / Amir Hooman Kazemi

Integrative Medicine Research, Vol 11, Iss 4, Pp 100898- (2022)

An assessor-blinded, randomized, controlled trial

2022

Abstract: Background: Non-pharmacological strategies that have been proposed by complementary medical systems, can be effective in management of COVID-19. Methods: This study was designed as a three-arm, assessor-blinded, randomized controlled trial. A total of ... ...

Abstract	Background: Non-pharmacological strategies that have been proposed by complementary medical systems, can be effective in management of COVID-19. Methods: This study was designed as a three-arm, assessor-blinded, randomized controlled trial. A total of 139 hospitalized COVID-19 patients were randomly assigned into three groups: (1) acupuncture (ACUG), (2) cupping (CUPG), and (3) control (CTRG). All participants received conventional treatment. The primary study endpoint included changes in respiratory signs including oxygen saturation (SpO2) and respiratory rate (RR). The secondary endpoints were COVID-19-related hospitalization duration and serious adverse events such as intensive care unit (ICU) admission, intubation or death, all up to day 30. Also, improvements in cough, dyspnea, chest tightness, oxygen demand, anorexia, headache, weakness, sore throat, and myalgia were evaluated. Results: Forty-two patients in ACUG, 44 patients in CUPG, and 42 patients in CTRG completed the trial. After 3 days, SpO2 and RR improved significantly in CUPG and ACUG compared with CTRG (effect size: 8.49 (6.4 to 10.57) and 8.51 (6.67 to 10.34), respectively: p<0.001). Compared with CTRG, patients in CUPG and ACUG recovered faster (mean difference: 6.58 (4.8 to 8.35) and 9.16 (7.16 to 11.15), respectively) and except for two patients in ACUG who were admitted to ICU, none of patients in ACUG or CUPG needed ICU or intubation (p<0.001 in comparison to CTRG). Amelioration of clinical COVID-19 related symptoms reached a high level of statistical significance in CUPG and ACUG in comparison with CTRG (p<0.01). Conclusion: Cupping and acupuncture are promising safe and effective therapies in management of COVID-19. Trial registration: This study was registered at Iranian Registry of Clinical Trials: IRCT20201127049504N1 (https://en.irct.ir/trial/52621).
Keywords	COVID-19 ; Persian medicine ; Traditional Chinese Medicine ; Cupping therapy ; Acupuncture ; Miscellaneous systems and treatments ; RZ409.7-999
Subject code	610
Language	English
Publishing date	2022-12-01T00:00:00Z
Publisher	Elsevier
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial.

Honarkar Shafie, Elaheh / Taheri, Fateme / Alijani, Neda / Okhovvat, Ahmad Reza / Goudarzi, Razieh / Borumandnia, Nasrin / Aghaghazvini, Leila / Rezayat, Seyed Mahdi / Jamalimoghadamsiahkali, Saeidreza / Hosseinzadeh-Attar, Mohammad Javad

Phytotherapy research : PTR

2022 Volume 36, Issue 2, Page(s) 1013–1022

Abstract: It has been more than a year since the outbreak of COVID-19, and it is still the most critical issue of the healthcare system. Discovering effective strategies to treat infected patients is necessary to decrease the mortality rate. This study aimed to ... ...

Abstract	It has been more than a year since the outbreak of COVID-19, and it is still the most critical issue of the healthcare system. Discovering effective strategies to treat infected patients is necessary to decrease the mortality rate. This study aimed to determine the effects of nanocurcumin on the severity of symptoms and length of hospital stay (LOS) in COVID-19 patients. Forty-eight COVID-19 patients were randomly assigned into nanocurcumin (n = 24) and placebo (n = 24) groups receiving 160 mg/day nanocurcumin or placebo capsules for 6 days. Mean differences of O
MeSH term(s)	COVID-19 ; Dietary Supplements ; Double-Blind Method ; Humans ; Length of Stay ; SARS-CoV-2 ; Treatment Outcome
Language	English
Publishing date	2022-01-12
Publishing country	England
Document type	Journal Article ; Randomized Controlled Trial
ZDB-ID	639136-9
ISSN	1099-1573 ; 0951-418X
ISSN (online)	1099-1573
ISSN	0951-418X
DOI	10.1002/ptr.7374
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.B 3092: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID‐19: A randomized double‐blind placebo‐controlled trial

Phytotherapy research. 2022 Feb., v. 36, no. 2

2022

Abstract: It has been more than a year since the outbreak of COVID‐19, and it is still the most critical issue of the healthcare system. Discovering effective strategies to treat infected patients is necessary to decrease the mortality rate. This study aimed to ... ...

Abstract	It has been more than a year since the outbreak of COVID‐19, and it is still the most critical issue of the healthcare system. Discovering effective strategies to treat infected patients is necessary to decrease the mortality rate. This study aimed to determine the effects of nanocurcumin on the severity of symptoms and length of hospital stay (LOS) in COVID‐19 patients. Forty‐eight COVID‐19 patients were randomly assigned into nanocurcumin (n = 24) and placebo (n = 24) groups receiving 160 mg/day nanocurcumin or placebo capsules for 6 days. Mean differences of O₂ saturation were significantly higher in patients who received nanocurcumin supplements (p = 0.02). Also, nanocurcumin treatment significantly reduced the scores of domains 3 and 4 and the total score of Wisconsin Upper Respiratory System Survey (WURSS‐24), indicating milder symptoms in the treatment group (p = 0.01, 0.03, and 0.01 respectively). Besides, the LOS in curcumin groups was lower than in the placebo group, although the difference was not statistically significant (6.31 ± 5.26 vs. 8.87 ± 8.12 days; p = 0.416). CBC/differentiate, hs‐CRP level and the pulmonary involvement in CT scan were not different between the two groups. As nanocurcumin can be effective in increasing O₂ saturation and reducing the severity of symptoms in COVID‐19 patients, it could probably be used as a complementary agent to accelerate the recovery of patients.
Keywords	COVID-19 infection ; computed tomography ; curcumin ; health services ; hospitals ; mortality ; phytotherapy ; placebos ; research ; respiratory system ; surveys ; Wisconsin
Language	English
Dates of publication	2022-02
Size	p. 1013-1022.
Publishing place	John Wiley & Sons, Ltd.
Document type	Article
Note	JOURNAL ARTICLE
ZDB-ID	639136-9
ISSN	1099-1573 ; 0951-418X
ISSN (online)	1099-1573
ISSN	0951-418X
DOI	10.1002/ptr.7374
Database	NAL-Catalogue (AGRICOLA)

In stock of ZB MED Cologne/Königswinter

Zs.B 3092: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Treatment With 25-Hydroxyvitamin D

Maghbooli, Zhila / Sahraian, Mohammad Ali / Jamalimoghadamsiahkali, Saeidreza / Asadi, Asma / Zarei, Azadeh / Zendehdel, Abolfazl / Varzandi, Tarlan / Mohammadnabi, Sara / Alijani, Neda / Karimi, Mehrdad / Shirvani, Arash / Holick, Michael F

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

2021 Volume 27, Issue 12, Page(s) 1242–1251

Abstract: Objective: The goal of this randomized, double-blinded, placebo-controlled clinical trial was to investigate the therapeutic efficacy of oral 25-hydroxyvitamin D: Methods: This is a multicenter, randomized, double-blinded, placebo-controlled clinical ...

Abstract	Objective: The goal of this randomized, double-blinded, placebo-controlled clinical trial was to investigate the therapeutic efficacy of oral 25-hydroxyvitamin D Methods: This is a multicenter, randomized, double-blinded, placebo-controlled clinical trial. Participants were recruited from 3 hospitals that are affiliated to [Institution Blinded for Review] and [Institution Blinded for Review]. Results: A total 106 hospitalized patients who had a circulating 25(OH)D Conclusion: Our analysis indicated that oral 25(OH)D
MeSH term(s)	COVID-19 ; Calcifediol ; Cholecalciferol/therapeutic use ; Dietary Supplements ; Double-Blind Method ; Humans ; Neutrophils ; SARS-CoV-2 ; Severity of Illness Index ; Vitamin D/analogs & derivatives ; Vitamin D Deficiency/drug therapy
Chemical Substances	Vitamin D (1406-16-2) ; Cholecalciferol (1C6V77QF41) ; 25-hydroxyvitamin D (A288AR3C9H) ; Calcifediol (P6YZ13C99Q)
Language	English
Publishing date	2021-10-13
Publishing country	United States
Document type	Journal Article ; Multicenter Study ; Randomized Controlled Trial
ZDB-ID	1473503-9
ISSN	1530-891X
ISSN	1530-891X
DOI	10.1016/j.eprac.2021.09.016
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5034: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 508: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.

JamaliMoghadamSiahkali, Saeidreza / Zarezade, Besharat / Koolaji, Sogol / SeyedAlinaghi, SeyedAhmad / Zendehdel, Abolfazl / Tabarestani, Mohammad / Sekhavati Moghadam, Ehsan / Abbasian, Ladan / Dehghan Manshadi, Seyed Ali / Salehi, Mohamadreza / Hasannezhad, Malihe / Ghaderkhani, Sara / Meidani, Mohsen / Salahshour, Faeze / Jafari, Fatemeh / Manafi, Navid / Ghiasvand, Fereshteh

European journal of medical research

2021 Volume 26, Issue 1, Page(s) 20

Abstract: Background: Vitamin C is an essential water-soluble nutrient that functions as a key antioxidant and has been proven to be effective for boosting immunity. In this study, we aimed to assess the efficacy of adding high-dose intravenous vitamin C (HDIVC) ... ...

Abstract	Background: Vitamin C is an essential water-soluble nutrient that functions as a key antioxidant and has been proven to be effective for boosting immunity. In this study, we aimed to assess the efficacy of adding high-dose intravenous vitamin C (HDIVC) to the regimens for patients with severe COVID-19 disease. Methods: An open-label, randomized, and controlled trial was conducted on patients with severe COVID-19 infection. The case and control treatment groups each consisted of 30 patients. The control group received lopinavir/ritonavir and hydroxychloroquine and the case group received HDIVC (6 g daily) added to the same regimen. Results: There were no statistically significant differences between two groups with respect to age and gender, laboratory results, and underlying diseases. The mean body temperature was significantly lower in the case group on the 3rd day of hospitalization (p = 0.001). Peripheral capillary oxygen saturations (SpO Conclusions: We did not find significantly better outcomes in the group who were treated with HDIVC in addition to the main treatment regimen at discharge. Trial registration irct.ir (IRCT20200411047025N1), April 14, 2020.
MeSH term(s)	Antiviral Agents/administration & dosage ; Antiviral Agents/therapeutic use ; Ascorbic Acid/administration & dosage ; Ascorbic Acid/therapeutic use ; Body Temperature ; COVID-19/drug therapy ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Intensive Care Units ; Length of Stay ; Lopinavir/therapeutic use ; Male ; Middle Aged ; Oxygen/blood ; Respiratory Distress Syndrome/drug therapy ; Respiratory Distress Syndrome/virology ; Ritonavir/therapeutic use ; Treatment Outcome
Chemical Substances	Antiviral Agents ; Lopinavir (2494G1JF75) ; Hydroxychloroquine (4QWG6N8QKH) ; Ritonavir (O3J8G9O825) ; Ascorbic Acid (PQ6CK8PD0R) ; Oxygen (S88TT14065)
Language	English
Publishing date	2021-02-11
Publishing country	England
Document type	Journal Article ; Randomized Controlled Trial
ZDB-ID	1329381-3
ISSN	2047-783X ; 0949-2321
ISSN (online)	2047-783X
ISSN	0949-2321
DOI	10.1186/s40001-021-00490-1
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4636: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern.

Salehi, Mohammadreza / Ahmadikia, Kazem / Mahmoudi, Shahram / Kalantari, Saeed / Jamalimoghadamsiahkali, Saeidreza / Izadi, Alireza / Kord, Mohammad / Dehghan Manshadi, Seyed Ali / Seifi, Arash / Ghiasvand, Fereshteh / Khajavirad, Nasim / Ebrahimi, Saeedeh / Koohfar, Amirhossein / Boekhout, Teun / Khodavaisy, Sadegh

Mycoses

2020 Volume 63, Issue 8, Page(s) 771–778

Abstract: Background: Emergence of coronavirus disease 2019 (COVID-19) is a major healthcare threat. Apparently, the novel coronavirus (SARS-CoV-2) is armed by special abilities to spread and dysregulate the immune mechanisms. The likelihood of oropharyngeal ... ...

Abstract	Background: Emergence of coronavirus disease 2019 (COVID-19) is a major healthcare threat. Apparently, the novel coronavirus (SARS-CoV-2) is armed by special abilities to spread and dysregulate the immune mechanisms. The likelihood of oropharyngeal candidiasis (OPC) development in COVID-19 patients with a list of attributable risk factors for oral infections has not yet been investigated. Objectives: We here aim to investigate the prevalence, causative agents and antifungal susceptibility pattern of OPC in Iranian COVID-19 patients. Patients and methods: A total of 53 hospitalised COVID-19 patients with OPC were studied. Relevant clinical data were mined. Strain identification was performed by 21-plex PCR and sequencing of the internal transcribed spacer region (ITS1-5.8S-ITS2). Antifungal susceptibility testing to fluconazole, itraconazole, voriconazole, amphotericin B, caspofungin, micafungin and anidulafungin was performed according to the CLSI broth dilution method. Results: In 53 COVID-19 patients with OPC, cardiovascular diseases (52.83%) and diabetes (37.7%) were the principal underlying conditions. The most common risk factor was lymphopaenia (71%). In total, 65 Candida isolates causing OPC were recovered. C albicans (70.7%) was the most common, followed by C glabrata (10.7%), C dubliniensis (9.2%), C parapsilosis sensu stricto (4.6%), C tropicalis (3%) and Pichia kudriavzevii (=C krusei, 1.5%). Majority of the Candida isolates were susceptible to all three classes of antifungal drugs. Conclusion: Our data clarified some concerns regarding the occurrence of OPC in Iranian COVID-19 patients. Further studies should be conducted to design an appropriate prophylaxis programme and improve management of OPC in critically ill COVID-19 patients.
MeSH term(s)	Adult ; Aged ; Aged, 80 and over ; Antifungal Agents/pharmacology ; COVID-19 ; Candida/classification ; Candida/drug effects ; Candida/genetics ; Candidiasis, Oral/complications ; Candidiasis, Oral/microbiology ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Female ; Humans ; Iran ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Pandemics ; Phenotype ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Time Factors
Chemical Substances	Antifungal Agents
Keywords	covid19
Language	English
Publishing date	2020-07-23
Publishing country	Germany
Document type	Journal Article
ZDB-ID	392487-7
ISSN	1439-0507 ; 0933-7407
ISSN (online)	1439-0507
ISSN	0933-7407
DOI	10.1111/myc.13137
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ud II Zs.176: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Oropharyngeal candidiasis in hospitalised COVID‐19 patients from Iran

Mycoses

Species identification and antifungal susceptibility pattern

2020 Volume 63, Issue 8, Page(s) 771–778

Keywords	Infectious Diseases ; Dermatology ; General Medicine ; covid19
Language	English
Publisher	Wiley
Publishing country	us
Document type	Article ; Online
ZDB-ID	392487-7
ISSN	1439-0507 ; 0933-7407
ISSN (online)	1439-0507
ISSN	0933-7407
DOI	10.1111/myc.13137
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

In stock of ZB MED Cologne/Königswinter

Ud II Zs.176: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito